STERIS plc
NYSE-STE
Company Overview
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
Name
STERIS plc
CEO
Mr. Daniel A. Carestio
Website
www.steris.com
Sector
Health Care Equipment and Supplies
Year Founded
1985
Profile
Market Cap
$23.51B
EV
$25.81B
Shares Out
98.62M
Revenue
$5,234.82M
Employees
18,000
Margins
Gross
43.6%
EBITDA
25.7%
Operating
17.61%
Pre-Tax
13.59%
Net
7.64%
FCF
11.35%
Returns (5Yr Avg)
ROA
4.29%
ROTA
11.47%
ROE
7.12%
ROCE
9.07%
ROIC
6.37%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
$246.94
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$198.33M
Net Debt
$2,286.34M
Debt/Equity
0.39
EBIT/Interest
6.47
Growth (CAGR)
Rev 3Yr
15.39%
Rev 5Yr
13.01%
Rev 10Yr
12.17%
Dil EPS 3Yr
7.15%
Dil EPS 5Yr
1.57%
Dil EPS 10Yr
7.05%
Rev Fwd 2Yr
3.09%
EBITDA Fwd 2Yr
6.19%
EPS Fwd 2Yr
6.78%
EPS LT Growth Est
11%
Dividends
Yield
—
Payout
36.65%
DPS
$2.08
DPS Growth 3Yr
9.14%
DPS Growth 5Yr
8.87%
DPS Growth 10Yr
9.49%
DPS Growth Fwd 2Yr
10.64%